Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib

Detalles Bibliográficos
Autores principales: Yi, Jun Ho, Kim, Hye Ryoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439304/
https://www.ncbi.nlm.nih.gov/pubmed/30956968
http://dx.doi.org/10.5045/br.2019.54.1.77

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439304/
https://www.ncbi.nlm.nih.gov/pubmed/30956968
http://dx.doi.org/10.5045/br.2019.54.1.77

Ejemplares similares